Atlas Trials

Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder

Clinical trial NCT01238575 · COMPLETED

Trial details

NCT number
NCT01238575
Sponsor
Yale University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Pervasive Development Disorders
Start date
2011-12-01
Primary completion
2014-03-01
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.